Modulating inflammatory macrophages with an apoptotic body-inspired nanoparticle

Area of Science:

• Biomaterials Science
• Immunology
• Nanotechnology

Background:

• Macrophages are key immune cells that drive and resolve inflammation.
• Dysregulated macrophage activity contributes to various inflammatory diseases and tissue damage.
• Current anti-inflammatory drugs have limitations, including side effects and variable efficacy.

Purpose of the Study:

• To develop a nanoparticle-based therapeutic to modulate macrophage phenotype and resolve inflammation.
• To mimic the natural anti-inflammatory signals of apoptotic cells for therapeutic benefit.
• To create a drug-free nanoparticle strategy for treating inflammatory conditions.

Main Methods:

• Developed poly(lactide-co-glycolide) nanoparticles coated with phosphatidylserine (PS)-supplemented cell plasma membrane (PS-MNPs).
• PS-MNPs were designed to emulate apoptotic bodies and their anti-inflammatory signaling.
• Evaluated the effect of PS-MNPs on macrophage phenotype and cytokine production in vitro, including LPS-induced inflammation models.

Main Results:

• PS-MNPs effectively reduced pro-inflammatory cytokine expression, such as tumor necrosis factor α (TNFα).
• Co-treatment with PS-MNPs and lipopolysaccharide (LPS) showed a significant reduction in TNFα production.
• PS-MNP treatment led to reduced NFκB activation, indicating a shift away from inflammatory signaling.

Conclusions:

• Apoptotic body-inspired PS-MNPs can reprogram inflammatory macrophages towards an anti-inflammatory phenotype.
• This nanoparticle strategy offers a novel, drug-free approach to combat macrophage-mediated inflammation.
• PS-MNPs represent a promising therapeutic avenue for inflammatory diseases and a tool to study macrophage-apoptotic cell interactions.